Duchesnay
Duchesnay is a specialty pharmaceutical company with a long-standing commitment to women’s health. Convinced that women’s health is the key to the success of societies, they strive to enable each woman to reach her full potential. With over three decades of experience, they focus on research, development, and providing therapeutic options for women at every stage of life, from pregnancy to menopause. Their mission is to promote well-being and contribute to society by offering innovative treatments, guided by values of excellence, integrity, innovation, and collaboration.
Industries
Nr. of Employees
medium (51-250)
Patents
Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
US-9937132-B2
View DetailsPlurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
US-9526703-B2
View DetailsFormulation of doxylamine and pyridoxine and/or metabolites or salts thereof
US-9375404-B2
View DetailsFormulation of doxylamine and pyridoxine and/or metabolites or salts thereof
US-9089489-B2
View Details
Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
US-9937132-B2
View DetailsPlurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
US-9526703-B2
View DetailsFormulation of doxylamine and pyridoxine and/or metabolites or salts thereof
US-9375404-B2
View DetailsFormulation of doxylamine and pyridoxine and/or metabolites or salts thereof
US-9089489-B2
View DetailsProducts
Diclectin (doxylamine succinate + pyridoxine) delayed‑release tablets
Oral delayed‑release tablet combination for management of nausea and vomiting in pregnancy.
PregVit (prenatal/postpartum vitamin‑mineral supplement)
Oral vitamin‑mineral supplement formulated for prenatal and postpartum use.
Pregvit folic 5 (5 mg folic acid prenatal tablet)
High‑dose folic acid oral tablet intended for prenatal use.
Mictoryl (propiverine) oral formulations
Oral propiverine formulations including pediatric tablets and modified‑release capsules for urinary symptoms.
Osphena (ospemifene) tablets 60 mg
Oral ospemifene tablets indicated for specific menopausal conditions.
Slynd (drospirenone) oral tablets 4 mg
Progestin‑only oral contraceptive tablet.
Diclectin (doxylamine succinate + pyridoxine) delayed‑release tablets
Oral delayed‑release tablet combination for management of nausea and vomiting in pregnancy.
PregVit (prenatal/postpartum vitamin‑mineral supplement)
Oral vitamin‑mineral supplement formulated for prenatal and postpartum use.
Pregvit folic 5 (5 mg folic acid prenatal tablet)
High‑dose folic acid oral tablet intended for prenatal use.
Mictoryl (propiverine) oral formulations
Oral propiverine formulations including pediatric tablets and modified‑release capsules for urinary symptoms.
Osphena (ospemifene) tablets 60 mg
Oral ospemifene tablets indicated for specific menopausal conditions.
Slynd (drospirenone) oral tablets 4 mg
Progestin‑only oral contraceptive tablet.
Services
Telephone and web‑form service to answer clinical and product questions; operating hours and emergency guidance provided.
Processes returns for defective, expired or damaged products including authorization issuance, shipping instructions, verification, investigation and issuance of credit notes.
Contact channels for business development and partnerships to support licensing, distribution and strategic manufacturing relationships.
Telephone and web‑form service to answer clinical and product questions; operating hours and emergency guidance provided.
Processes returns for defective, expired or damaged products including authorization issuance, shipping instructions, verification, investigation and issuance of credit notes.
Contact channels for business development and partnerships to support licensing, distribution and strategic manufacturing relationships.
Expertise Areas
- Women’s health therapeutics
- Obstetrics and gynecology
- Contraception
- Prenatal and postpartum nutritional supplements
Key Technologies
- Delayed‑release tablet formulation
- Modified‑release capsule formulation
- Controlled‑release vaginal tablet formulation
- Oral tablet and capsule manufacturing